Application of botulinum toxin in maxillofacial field: part I. Bruxism and square jaw
Kyung-Hwan Kwon, Kyung Su Shin, Sung Hee Yeon, Dae Gun Kwon, Kyung-Hwan Kwon, Kyung Su Shin, Sung Hee Yeon, Dae Gun Kwon
Abstract
The application of botulinum in oral and maxillofacial surgery begins in 1982, where Jan Carruthers started using it for reducing the muscle mass and smoothing the skin, and since then it has been used for cosmetic purposes. In Korea, it is already being used by various specialties including dentistry (oral and maxillofacial surgery, oral medicine), plastic surgery, dermatology, ophthalmology, general surgery, and orthopedic surgery, etc. Each specialty approaches to Botox with its own medical indications. In this article, we will discuss the maxillofacial application of botulinum toxin, which includes theoretical and practical aspects of such as bruxism and square jaw.
Keywords: Botulinum toxin; Bruxism; Clinical application; Maxillofacial field; Square jaw.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
© The Author(s). 2019.
Figures
References
- Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87:1044–1049. doi: 10.1016/S0161-6420(80)35127-0.
- Selter PE. Therapeutic use of botulinum toxins: Background and History. Clin J Pain. 2002;18:119–124. doi: 10.1097/00002508-200211001-00002.
- Simpson LL. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochemie. 2000;82:943–953. doi: 10.1016/S0300-9084(00)01169-X.
- Freud B, Schwartz M, Symington J. The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings. J Oral Maxillofac Surg. 1999;57:916–920. doi: 10.1016/S0278-2391(99)90007-1.
- Lu Dave W., Lippitz Jonathan. Complications of Botulinum Neurotoxin. Disease-a-Month. 2009;55(4):198–211. doi: 10.1016/j.disamonth.2009.01.001.
- Popoff MR, Bouvet P. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon. 2013;75:63–89. doi: 10.1016/j.toxicon.2013.05.003.
- Van Zndiijcke M, Marchau MM (1990) Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990;53:530.
- Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br. J. Oral Maxillofacial Surg. 1994;32:29–33. doi: 10.1016/0266-4356(94)90169-4.
- Kim SY, Kim YK, Yun PY, Bae JH (2018) Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study. Dig Maxillofac Plast Reconstr Surg. 10.1186/s40902-018-0159-z
- Archana MS. Toxin yet not toxic: botulinum toxin in dentistry. Saudi Dent J. 2016;28:63–69. doi: 10.1016/j.sdentj.2015.08.002.
- Kwon TG (2016) Botulinum toxin related research in maxillofacial plastic and reconstructive surgery. Dig Maxillofac Plast Reconstr Surg. 10.1186/s40902-016-0080-2
- Carruthers J, Carruthers A. (1991) Botulinum toxin use on Glabells wrinkles. Presented at the annual meeting of the American Society for dermatologic surgery Orlando florida. 13-17 March. 1991
- Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17–21. doi: 10.1111/j.1524-4725.1992.tb03295.x.
- To EW. Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plat Surg. 2001;54:197–200. doi: 10.1054/bjps.2000.3526.
- Sano K, Ninomiya H, Ckine J, Michael B, Pe MB, Inokuchi T. Application of magnetic resonance imaging and ultrasonography to preoperative evaluation of masseteric hypertrophy. J Craniomaxillofac Surg. 1991;19:223–226. doi: 10.1016/S1010-5182(05)80552-9.
- Loder E, Biondi D. Use of botulinum toxins for chronic headaches: A focused review. The Clin J Pain. 2002;18:169–176. doi: 10.1097/00002508-200211001-00009.
- Pidcock FS, Wise JM, Christensen JR. Treatment of severe post-traumatic bruxism with botulinum toxin-A: Case Report. J Oral Maxillofac Surg. 2002;60:115–117. doi: 10.1053/joms.2002.29127.
- Ivanhoe CB, Lai JM, Francisco GE. Bruxism after brain injury: Successful treatment with Botulinum toxin-A. Arch Phys Med Rehabil. 1997;78:1272–1273. doi: 10.1016/S0003-9993(97)90343-9.
- Freund B, Schwartz M, Symington JM. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg. 1999;57:916–920. doi: 10.1016/S0278-2391(99)90007-1.
- Niamtu Joseph. Botulinum toxin A: A review of 1,085 oral and maxillofacial patient treatments. Journal of Oral and Maxillofacial Surgery. 2003;61(3):317–324. doi: 10.1053/joms.2003.50069.
- Attanasio R. An overview of bruxism and its management. Dent Clin North Am. 1997;41:229–241.
- Pratap-Chand R., Gourie-Devi M. Bruxism: its significance in coma. Clinical Neurology and Neurosurgery. 1985;87(2):113–117. doi: 10.1016/0303-8467(85)90107-6.
Source: PubMed